Efficacy and Safety of Acupoint Catgut Embedding for Obesity Associated with Polycystic Ovary Syndrome: A Qualitative and Quantitative Analysis
Diabetes, Metabolic Syndrome and Obesity · 2026-02 · Volume 19 · 1-15
DOI: 10.2147/dmso.s553787 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-02. Verfasst von Xing-Xian Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Acupuncture and Tuina College, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Aim
Obesity is common in women with polycystic ovary syndrome (PCOS) and can exacerbate PCOS symptoms. Although Acupoint catgut embedding (ACE) is frequently used to treat the clinical symptoms of simple obesity, it is unclear how it will affect obesity associated with PCOS. We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) to evaluate the effectiveness of ACE in treating obesity in women with PCOS.
Methods
We searched databases from inception to January 8, 2025. Two independent reviewers extracted data and assessed the risk of bias. All meta-analyses used random effects models, and the GRADE approach was used to assess the certainty of the evidence.
Results
We included 25 RCTs (1,663 participants). Based on usual care, compared to blank treatment, ACE probably reduces body mass index (BMI), waist-to-hip ratio (WHR), and waist circumference (WC), and may enable a greater proportion of patients to achieve a weight loss no less than 5% (relative risk [RR] 1.33, 95% CI 1.15 to 1.55) and may reduce triglycerides (TG). Furthermore, when compared to active comparators, ACE probably enables a greater proportion of patients to achieve a weight loss no less than 5% (RR 1.40, 95% CI 1.11 to 1.76) and reduces WC and may also reduce BMI and TG. All effects were supported by low to moderate certainty evidence.
Conclusion
When compared to blank treatment, on the basis of usual care, ACE for obesity associated with PCOS may improve obesity-related outcomes. When compared to active comparators, it may have comparable or greater therapeutic efficacy and fewer adverse events. Such improvements in obesity-related indicators may help alleviate metabolic and reproductive symptoms in women with PCOS. As all included trials were conducted in China, further high-quality studies in diverse populations are needed to confirm the generalizability of these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Acupuncture and Tuina College, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
- School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
ORCID-Profile: Wen-Bin Ma
Zitieren
APA
Li, X. X., Hu, Z. Y., Yuan, D. N., Zhao, J. X., Ma, W. B., & Lan, L. (2026). Efficacy and Safety of Acupoint Catgut Embedding for Obesity Associated with Polycystic Ovary Syndrome: A Qualitative and Quantitative Analysis. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-15. https://doi.org/10.2147/dmso.s553787
Vancouver
Li XX, Hu ZY, Yuan DN, Zhao JX, Ma WB, Lan L. Efficacy and Safety of Acupoint Catgut Embedding for Obesity Associated with Polycystic Ovary Syndrome: A Qualitative and Quantitative Analysis. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-15. doi:10.2147/dmso.s553787
BibTeX
@article{Li2026,
author = {Li, Xing-Xian and Hu, Zhuo-Ya and Yuan, Dong-Ni and Zhao, Jun-Xin and Ma, Wen-Bin and Lan, Lei},
title = {Efficacy and Safety of Acupoint Catgut Embedding for Obesity Associated with Polycystic Ovary Syndrome: A Qualitative and Quantitative Analysis},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--15},
doi = {10.2147/dmso.s553787}
}
EUVIMED